Elicio Therapeutics, Inc entered into a Subscription Agreement and completed a private placement of 1,213,000 shares par value $0.01 per share, at a purchase price per Share of $5.81 for gross proceeds of $1,213,000 on December 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.98 USD | +5.70% | +4.72% | -4.32% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.32% | 77.17M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $7.04753 million in funding